Status in the House - 91st Legislature (2019 - 2020)
Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.
| 01/22/2019 | |
| 01/24/2019 |
Authors added
Loeffler and Dehn
pg. 120
|
| 03/11/2019 |
Committee report, to adopt as amended and re-refer to
Health and Human Services Policy
pg. 937a
|
| 03/13/2019 |
Committee report, to adopt and re-refer to
Judiciary Finance and Civil Law Division
pg. 1013
|
| 03/20/2019 |
Author added
Persell
pg. 1510
|
| 04/01/2019 |
Author added
Bierman
pg. 1785
|
| House Actions | Senate Actions |
|---|---|
| 01/22/2019 | |
| 01/24/2019 | |
|
Authors added
Loeffler and Dehn
pg. 120
|
|
| 03/11/2019 | |
|
Committee report, to adopt as amended and re-refer to
Health and Human Services Policy
pg. 937a
|
|
| 03/13/2019 | |
|
Committee report, to adopt and re-refer to
Judiciary Finance and Civil Law Division
pg. 1013
|
|
| 03/20/2019 | |
|
Author added
Persell
pg. 1510
|
|
| 04/01/2019 | |
|
Author added
Bierman
pg. 1785
|
|